The stories buried, spiked, or spun.
Corporate Watchdog

Labcorp Settles $14.5M Medicare False Claims

Labcorp will pay $14.5 million to settle DOJ allegations of billing Medicare for medically unnecessary urine drug tests

Labcorp Settles $14.5M Medicare False Claims

Labcorp has agreed to pay $14.5 million to settle allegations by the Department of Justice that it billed Medicare for medically unnecessary urine drug tests from 2018 to 2023, as reported by CLP Magazine. This settlement is part of a larger effort by the DOJ to crack down on healthcare fraud, including Medicare fraud, which has been a significant problem in recent years, with various schemes targeting different states, such as those found in Medicaid fraud schemes targeting Minnesota. The DOJ has also been working to denaturalize individuals who have committed fraud, including healthcare fraud, as part of its largest denaturalization effort ever, which has led to actions being filed against individuals accused of serious offenses, including healthcare and wire fraud.

The Labcorp settlement is a significant development in the ongoing effort to combat Medicare fraud, which is a major concern for the official U.S. government website for Medicare, a health insurance program for people age 65 or older and younger people with disabilities. The House Oversight Committee has also been examining Medicare fraud, including a recent roundtable on skin-substitute spending, as part of its efforts to understand the scope of the problem and identify solutions. Meanwhile, the issue of denaturalization for individuals who commit fraud, including Medicare fraud, has been highlighted in cases such as that of Mirelys Cabrera Díaz, a Hialeah resident who was stripped of her citizenship after being sentenced to prison for participating in a Medicare fraud scheme, as reported by cubaheadlines.com. The use of data to track and prevent Medicare fraud has also been an area of focus, with some arguing that Medicaid fraud data is being unused, which could be hindering efforts to combat the problem.

The Labcorp settlement and the broader efforts to combat Medicare fraud are part of a larger landscape of financial crime and money laundering investigations, which are also being pursued in other countries, such as the UK corporate money laundering investigations rise. The financial details of the Labcorp settlement, including the $14.5 million payment, highlight the significant costs associated with Medicare fraud and the importance of preventing and detecting such fraud to protect the integrity of the healthcare system. As the DOJ continues to pursue denaturalization actions against individuals who commit fraud, including healthcare fraud, it is clear that the consequences for such actions can be severe, including the loss of U.S. citizenship, as highlighted in the case of Rodriguez Perez, a Cuban man charged with Medicare fraud, who faces the loss of his U.S. citizenship, as reported by cubaheadlines.com.

Jordan Ames
The Jordan Ames Take
Government Benefits Fraud & Financial Crime

As I reflect on the recent Labcorp settlement of 14.5 million dollars for Medicare false claims, I firmly believe that more stringent regulations are needed to prevent such abuses. If nothing changes, the real winners will be the fraudulent corporations like Labcorp, who will continue to reap profits at the expense of taxpayers and vulnerable Medicare beneficiaries. I believe that it is our responsibility to demand greater accountability and transparency in the healthcare industry to prevent such blatant disregard for the law and ensure that those who abuse the system are held to a higher standard of integrity.

Primary source: CLP Magazine
Cross-reference independently — do not take our word for it.
How We Report Corporate Watchdog

This article is produced by NewsAnarchist's AI reporting system, not a human staff reporter. It's built from the primary source cited above (a regulator's enforcement action (SEC, FTC, DOJ), a company's own SEC filing, a court record, or the wire/trade-press reporting linked in the body) and reports what that source states, attributed to it — it is not a recommendation about any company's stock or products, and does not verify a company's disputed denial beyond what the record shows. Part of our Corporate Watchdog hub. Found an error? Tell us.

THE DAILY BRIEFING
Get the stories buried, spiked, or spun — free every morning.
No spam. No ads. Unsubscribe anytime.